🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Investigational Drug Acquiring Popularity Online

The experimental drug, which remains in research studies, is being promoted by online personalities for its alleged fat-burning effects. Viewers are urged to contact these profiles directly for source information, while also obtaining promotional offers.

Active Trade on Social Networks

Additionally, a robust trade exists on messaging services, where groups with numerous of participants share “before and after” photos, injection guides and assertions of next-day UK delivery. Sellers promote the substance there before directing customers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Experts Express Concerns

However, physicians and pharmacists have cautions that the sale of what remains an unapproved medication in the United Kingdom is worrisome and could result in users administering substances of unknown origin.

Several professionals said the popularity for retatrutide could be connected to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still violate pharmaceutical, advertising, and consumer laws, potentially leading to fines, prosecution or imprisonment.

Platform Reaction and Content Elimination

According to TikTok, the service has taken down problematic material and banned related hashtags and search suggestions. The company stated it was committed to maintaining the service secure and investing in strengthening enforcement strategies.

Digital Trading Activities

Research also found communities with up to nine thousand members selling retatrutide using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately displays groups with thousands of members, filled with images of weight loss, positive reviews and step-by-step guides for mixing or administering at home.

After minutes of joining one group, a seller shared WhatsApp details, where the majority of purchases occur. The seller provided an guidebook and guaranteed delivery within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None inquired about weight, health issues or previous experience.

Item Information and Costs

Inside these groups, posts display black plastic packages with Royal Mail stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with sterile water, or pre-filled injectors usually sold at 160 pounds for 20 milligrams. When questioned how much time a injector should last, sellers give contradictory responses ranging from a several days to “depends on your body”.

Platform Oversight and Security Actions

A representative for Telegram stated it regularly monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting substances they cannot confirm. Even if the science behind retatrutide is sound, these digital products may not include what they advertise,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit injections are highly risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her staff has previously seen patients harmed by personal administration from unverified suppliers. “We understand the frustration, but buying from Telegram or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject patients to potentially serious health risks”.